Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01131871
Other study ID # U01HL096770
Secondary ID
Status Completed
Phase Phase 2
First received May 24, 2010
Last updated August 4, 2015
Start date September 2010
Est. completion date November 2014

Study information

Verified date August 2015
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The prevalence of obesity in young adults has been increasing, and excessive body weight have been linked to numerous chronic conditions including cardiovascular disease, diabetes, many forms of cancer, and numerous musculoskeletal problems. This study will focus of the development and evaluation of interventions that may be appropriate for young adults (age 18-35 years) to improve weight loss outcomes following a 24 month intervention. The primary aim of this study is to examine whether an enhanced weight loss intervention (EWLI) that includes technology components results in improved weight loss in young adults (18-35 years of age) compared to a standard behavioral weight loss intervention (SBWP) over a period of 24 months. Eligible participants will also be assessed for body composition, body fat distribution, fitness, physical activity, dietary intake, and behavioral/psychosocial measures that may be predictive of behavior change. Assessments will occur at 0, 6, 12, 18, and 24 months. Subjects will participate in a 24 month behavioral weight loss program that includes a reduction in energy intake and moderate-to-vigorous intensity exercise (progressively increasing from 100 to 300 minutes per week). The technologies added to EWLI are text messaging, a wearable device that provides feedback on physical activity, and access to a website to monitor dietary behaviors.


Recruitment information / eligibility

Status Completed
Enrollment 471
Est. completion date November 2014
Est. primary completion date November 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- 18-35 years of age

- Intending to be available for a 24 month intervention

- An active cellular telephone that is capable of receiving text messaging

- A computer and internet connectivity that can be used for the BodyMedia Fit system

- Body mass index (BMI) between 25.0-39.9 kg/m2

- The ability to provide medical clearance to participate in this study from their primary care physician

- The ability to complete the baseline graded exercise test, and clearance from the study physician to participate in this study after reviewing the results from this study

Exclusion Criteria:

- Unable to provide informed consent

- Household member on study staff

- Past or planned (within the next 24 months) weight loss surgery (e.g. gastric bypass, lap band, or liposuction); current participation in a commercial weight loss program (e.g. Weight Watcher's, Jenny Craig); current or planned enrollment in another diet/PA/weight loss intervention study

- Report regular use of systemic steroids, prescription weight loss drugs. "Regular use" is defined as "taking this medication most days of the week for the previous month"

- Current treatment for eating disorder

- Cardiovascular event (heart attack, stroke, episode of heart failure, or revascularization procedure) within the last 6 months

- Current treatment for malignancy (other than non-melanoma skin cancer)

- Currently pregnant or gave birth within the last 6 months, currently lactating or breastfeeding within the last 3 months, actively planning pregnancy within the next 24 months

- Investigator discretion

- Currently taking medication that would affect heart rate or blood pressure responses to exercise (e.g., beta blockers)

- Report losing >5% of current body weight in the previous 6 months

- Currently treated for psychological issues, or taking psychotropic medications within the previous 6 months

- Report taking medication that could affect metabolism or change body weight

- Current treatment for diabetes mellitus

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Standard Behavioral Weight Loss Intervention
Subjects in this group will receive our standard behavioral weight control program that is delivered in an in-person group-based format. At month 7 subjects will also be given access to a study website to monitor eating and activity behaviors, and to have electronic access to standardized intervention materials. At month 7 subjects will also receive targeted study-related text messages that otherwise would have been provided in paper format.
Enhanced Weight Loss Intervention
Subjects in this group will participate in a weight loss intervention that includes technology enhancements. These enhancements will include the addition of intervention specific targeted and tailored text messaging and the BodyMedia Fit System® beginning at Month 7. At month 7 subjects in EWLI will also receive the same targeted study-related text messages provided to SBWP that otherwise would have been provided in paper format.

Locations

Country Name City State
United States University of Pittsburgh Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pittsburgh

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary weight change Body weight will be assessed on a digital scale to assess change in body weight over the 24 month intervention period. Change from baseline to 24 months No
Secondary body composition Body composition will be assessed using DXA. This will provide a measure of lean body mass, fat mass, bone mineral content, and percent body fat. 0, 6, 12, 18 24 months No
Secondary cardiorespiratory fitness A graded exercise test on a treadmill along with indirect calorimetry will be used to measure cardiorespiratory fitness. This will provide a measure of oxygen consumption and metabolic equivalents of work at the time of test termination. 0, 6, 12, 18, 24 months No
Secondary physical activity energy expenditure A questionnaire and a portable device worn on the upper arm will be used to measure and quantify energy expenditure from physical activity. 0, 6, 12, 18, 24 months No
Secondary dietary intake A questionnaire will be used to assess self-reported food intake. This will be used to estimate calories, dietary fat, protein, and carbohydrates consumed. 0, 6, 12, 18, 24 months No
Secondary psychosocial and behavioral measures Questionnaires will be used to assess self-efficacy for weight loss and physical activity, barriers to physical activity and weight loss, expected outcomes resulting from physical activity and weight loss, perceived body image, depressive symptomotology, sleep patterns, weight history, dietary disinhibition and restraint, and behaviors typically related to weight loss (e.g., self-weighing, meal planning, etc.). 0, 6, 12, 18, 24 months No
See also
  Status Clinical Trial Phase
Completed NCT04085861 - Mental Health in Dancers; an Intervention Study N/A
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Not yet recruiting NCT06026631 - Lipidomic Characterization in Non-metastatic Breast Cancer Women Undergoing Surgery: a Pilot Study. N/A
Completed NCT03850990 - Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss N/A
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Completed NCT02899559 - Messages and Plans to Increase Gym Utilization N/A
Active, not recruiting NCT02557022 - Meta Analysis of the Effect of a Low Glycemic Index Diet and Glycemic Load on Body Weight N/A
Completed NCT02158130 - Effects of Aerobic Exercise Detraining N/A
Completed NCT02188251 - A Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants Phase 2
Completed NCT02402985 - Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics N/A
Completed NCT01665339 - Preload, Weight Management, Risk of Cardiovascular Disease Phase 3
Completed NCT01170390 - Oral Contraceptives and Body Mass Index Phase 4
Completed NCT02395835 - Methylation of the PPARg Promoter Region in Pregnancy N/A
Completed NCT00814554 - Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers N/A
Completed NCT04901949 - The Course of Acute Pancreatitis in Patients With Different BMI Groups
Active, not recruiting NCT03843424 - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers N/A
Active, not recruiting NCT03575897 - Serial Assessment of Body Fat Accrual in Very Preterm Infants N/A
Active, not recruiting NCT05601804 - TARGETing Healthy Weight Loss in the Context of Food Insecurity
Not yet recruiting NCT05004558 - Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias N/A
Active, not recruiting NCT04399460 - The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control N/A